DropGenie
PrivateLast Round
Seed+
Oct 26, 2026
Total Funding Raised
$5.11M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
DropGenie operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed+ round in October 2026.
DropGenie is a biotechnology company that provides a microfluidics-based platform to miniaturize and automate gene editing workflows, enabling high-throughput cell engineering in precious patient samples for applications in personalized medicine and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DropGenie Comparables
Compare DropGenie with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Portal Biotechnologies | 87% | |
| Kytopen | 84% | |
| Indee Labs | 83% |
For institutional investors. Book with your work email.
DropGenie Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed+ | Oct 26, 2026 | ||||
| Accelerator | Mar 13, 2026 | ||||
| Accelerator | Jul 6, 2022 | ||||
| Accelerator | Jan 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DropGenie Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Seed+, Accelerator |
| BDC Capital | Seed+ |
| Skeleton Key | Seed+ |
| Anges Quebec | Seed+ |
| Real Ventures | Seed+ |
| BioTools Innovator | Accelerator |
| Merck Capital Ventures | Seed+, Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 2, 4x the trailing average.
- Jun 22, 2026
Led by Skeleton Key with participation from Merck Capital Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 26, 2026
DropGenie, Inc. partners with AbbVie Inc. as part of its effort to bring its chip-based product to market.
- partners_withOct 26, 2026
DropGenie, Inc. partners with Sartorius, a life-science instrument company, as part of its partnerships supporting faster, lower-volume genetic screening.
- receives_financingOct 26, 2026
DropGenie, Inc. secures $5M Seed Plus financing on Oct 26th '26 in Canada from BDC Thrive Venture Fund alongside Skeleton Key, with participation from Merck Global Health Innovation Fund, CQDM, Real Ventures and Anges Quebec, to scale its functional biology platform and data partnerships.
- partners_withOct 26, 2026
DropGenie, Inc. partners with UCB Pharma SA as part of partnerships with pharmaceutical and life science instrument companies.
- partners_withOct 26, 2026
DropGenie, Inc. partners with Danaher Corporation as part of DropGenie’s partnerships with pharmaceutical and life science instrument companies.
For institutional investors. Book with your work email.
DropGenie Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DropGenie's valuation, stock price, and market status.
Is DropGenie a public or private company?
DropGenie is a private company.
What is the current stock price of DropGenie?
DropGenie is a private company, so its shares have no public market price. Caplight tracks DropGenie's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DropGenie worth (valuation)?
Valuation information for DropGenie is not publicly available.
Can I buy DropGenie stock?
DropGenie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DropGenie's last funding round?
DropGenie's most recent funding round was Seed+ on October 26, 2026.
Who are the main investors in DropGenie?
Key investors in DropGenie include Skeleton Key.
Will DropGenie IPO soon?
No public IPO plans have been announced for DropGenie.
How can I track DropGenie secondary market activity?
Caplight tracks bids, offers, and trades in DropGenie's shares on secondary markets.